Pub Date : 2023-09-07DOI: 10.1177/26345161231198622
Alexander T. Reddy, S. Posner, Matthew Harbrecht, Nicholas Koutlas, Jonathan Reichstein, Sarah Cantrell, D. Leiman
The RDQ was developed to assist in diagnosing GERD, but is now widely used in multiple contexts and validated in several languages. However, there is no standard RDQ scoring rubric, making comparisons between its uses challenging. Therefore, we performed a scoping review to explore the current applications and scoring cutoffs of the RDQ. The MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Web of Science electronic databases were systematically searched from January 2001 to January 2021 by a medical librarian using controlled vocabulary terms and keywords to identify experimental and observational study designs. The search strategy yielded 5707 studies and 116 met inclusion criteria yielding a total patient population of 115 064. Studies utilized the RDQ to establish a GERD diagnosis (n = 52, 45%), report the prevalence of GERD symptoms within a specific population (n = 21, 18%), and assess the effect of an intervention on symptoms (n = 43, 37%). There was variability between the scoring threshold used for diagnosing GERD, with total GERD domain score ≥12 being the most commonly used (n = 16, 14%). The RDQ was designed as an aid for diagnosing GERD, but scoring methods and thresholds vary and the RDQ now is used to describe the prevalence of GERD symptoms and to assess symptom response to intervention. Based on the current review, the use of RDQ appears best suited for comparing diagnostic or treatment cohorts in which symptoms are evaluated. Interpretation of RDQ findings outside of a study-specific context is limited without accepted scoring standards.
{"title":"Reflux Disease Questionnaire Scoring and Utilization: A Scoping Review","authors":"Alexander T. Reddy, S. Posner, Matthew Harbrecht, Nicholas Koutlas, Jonathan Reichstein, Sarah Cantrell, D. Leiman","doi":"10.1177/26345161231198622","DOIUrl":"https://doi.org/10.1177/26345161231198622","url":null,"abstract":"The RDQ was developed to assist in diagnosing GERD, but is now widely used in multiple contexts and validated in several languages. However, there is no standard RDQ scoring rubric, making comparisons between its uses challenging. Therefore, we performed a scoping review to explore the current applications and scoring cutoffs of the RDQ. The MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Web of Science electronic databases were systematically searched from January 2001 to January 2021 by a medical librarian using controlled vocabulary terms and keywords to identify experimental and observational study designs. The search strategy yielded 5707 studies and 116 met inclusion criteria yielding a total patient population of 115 064. Studies utilized the RDQ to establish a GERD diagnosis (n = 52, 45%), report the prevalence of GERD symptoms within a specific population (n = 21, 18%), and assess the effect of an intervention on symptoms (n = 43, 37%). There was variability between the scoring threshold used for diagnosing GERD, with total GERD domain score ≥12 being the most commonly used (n = 16, 14%). The RDQ was designed as an aid for diagnosing GERD, but scoring methods and thresholds vary and the RDQ now is used to describe the prevalence of GERD symptoms and to assess symptom response to intervention. Based on the current review, the use of RDQ appears best suited for comparing diagnostic or treatment cohorts in which symptoms are evaluated. Interpretation of RDQ findings outside of a study-specific context is limited without accepted scoring standards.","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41372212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-07DOI: 10.1177/26345161231198626
S. Kodaganur Gopinath, S. Jiwnani
Esophageal cancer is amongst the most common types of cancer in Asia. It is a deadly disease where incidence almost parallels mortality. It is of 2 major subtypes, adenocarcinoma being more common in the global north and squamous cell carcinoma being more common in the global south. China, Japan, India, Iran, and other Asian countries contribute to roughly 80% of the global disease burden. Fortunately, esophageal squamous cell cancers (ESCC) are also amenable for screening. Natural history studies have shown that severe dysplasia carries the highest risk of progression to ESCC. Early detection has shown to be extremely beneficial, with cure rates above 90% for precursor lesions and early-stage esophageal cancer. There are various modalities available for screening—Chinese balloon cytology is a low cost technique that can be applied for mass screening but has only moderate sensitivity (39%-62%). Recent studies have demonstrated that using methylated DNA markers and applying artificial intelligence technology can significantly improve the yield of cytology. Lugol’s chromo-endoscopy has been demonstrated to have good sensitivity and specificity (>85%), but is an invasive technique and requires operator expertise. Other image enhancing techniques such as narrow-band imaging, autofluorescence, endocytoscopy and micro-endoscopy are promising, but currently not cost effective for mass screening. There are 3 large randomized trials underway in China, initial published results have demonstrated a detection rate between 0.7% to 1.2% for ESCC and 4% to 6% for pre cursor lesions. These trials, with some of them involving >100 000 patients have demonstrated the feasibility of endoscopic screening, but long term results are awaited.
{"title":"Screening for Esophageal Squamous Cell Carcinoma: A Review","authors":"S. Kodaganur Gopinath, S. Jiwnani","doi":"10.1177/26345161231198626","DOIUrl":"https://doi.org/10.1177/26345161231198626","url":null,"abstract":"Esophageal cancer is amongst the most common types of cancer in Asia. It is a deadly disease where incidence almost parallels mortality. It is of 2 major subtypes, adenocarcinoma being more common in the global north and squamous cell carcinoma being more common in the global south. China, Japan, India, Iran, and other Asian countries contribute to roughly 80% of the global disease burden. Fortunately, esophageal squamous cell cancers (ESCC) are also amenable for screening. Natural history studies have shown that severe dysplasia carries the highest risk of progression to ESCC. Early detection has shown to be extremely beneficial, with cure rates above 90% for precursor lesions and early-stage esophageal cancer. There are various modalities available for screening—Chinese balloon cytology is a low cost technique that can be applied for mass screening but has only moderate sensitivity (39%-62%). Recent studies have demonstrated that using methylated DNA markers and applying artificial intelligence technology can significantly improve the yield of cytology. Lugol’s chromo-endoscopy has been demonstrated to have good sensitivity and specificity (>85%), but is an invasive technique and requires operator expertise. Other image enhancing techniques such as narrow-band imaging, autofluorescence, endocytoscopy and micro-endoscopy are promising, but currently not cost effective for mass screening. There are 3 large randomized trials underway in China, initial published results have demonstrated a detection rate between 0.7% to 1.2% for ESCC and 4% to 6% for pre cursor lesions. These trials, with some of them involving >100 000 patients have demonstrated the feasibility of endoscopic screening, but long term results are awaited.","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48561016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231198617
Felice Schnoll-Sussman
Care for patients with dysplastic Barrett’s esophagus is rooted in endoscopic ablative therapies. Radiofrequency ablation (RFA), cryotherapy and argon plasma coagulation, in conjunction with endoscopic resection techniques and optimized pharmacologic and surgical therapy of reflux can lead to complete eradication when the appropriate ablative technology is used in the appropriate Barrett’s patient. This article reviews the critical decisions and technical considerations necessary to be successful in this aspect of Barrett’s care. Use of a cap device, optimal pre ablation preparation and technical aspects of RFA, cryotherapy and argon plasma coagulation are discussed. A detailed algorithm, that if followed, will greatly improve the opportunity for success is presented.
{"title":"Critical Decision Making: Technical Aspects of Esophageal Ablation","authors":"Felice Schnoll-Sussman","doi":"10.1177/26345161231198617","DOIUrl":"https://doi.org/10.1177/26345161231198617","url":null,"abstract":"Care for patients with dysplastic Barrett’s esophagus is rooted in endoscopic ablative therapies. Radiofrequency ablation (RFA), cryotherapy and argon plasma coagulation, in conjunction with endoscopic resection techniques and optimized pharmacologic and surgical therapy of reflux can lead to complete eradication when the appropriate ablative technology is used in the appropriate Barrett’s patient. This article reviews the critical decisions and technical considerations necessary to be successful in this aspect of Barrett’s care. Use of a cap device, optimal pre ablation preparation and technical aspects of RFA, cryotherapy and argon plasma coagulation are discussed. A detailed algorithm, that if followed, will greatly improve the opportunity for success is presented.","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135346822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231196002
Thorsten Lehmann, Mantas Simkus, Christoph Oehler
Restricted accessAbstractFirst published online September 22, 2023Topic: Endoscopic Foregut Surgery (Including Endobariatrics)Abstract ID: 82A Retrospective Chart Review of 79 Patients Undergoing the Refluxstop™ Procedure to Manage Gastroesophageal Reflux Disease: Safety and EfficacyThorsten Lehmann, Mantas Simkus, and Christoph OehlerView all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231196002
{"title":"Topic: Endoscopic Foregut Surgery (Including Endobariatrics)Abstract ID: 82A Retrospective Chart Review of 79 Patients Undergoing the Refluxstop™ Procedure to Manage Gastroesophageal Reflux Disease: Safety and Efficacy","authors":"Thorsten Lehmann, Mantas Simkus, Christoph Oehler","doi":"10.1177/26345161231196002","DOIUrl":"https://doi.org/10.1177/26345161231196002","url":null,"abstract":"Restricted accessAbstractFirst published online September 22, 2023Topic: Endoscopic Foregut Surgery (Including Endobariatrics)Abstract ID: 82A Retrospective Chart Review of 79 Patients Undergoing the Refluxstop™ Procedure to Manage Gastroesophageal Reflux Disease: Safety and EfficacyThorsten Lehmann, Mantas Simkus, and Christoph OehlerView all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231196002","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231189086
Clive Miranda, Murad Ali, Muddasir Ayaz, Gregory Gudleski, Thomas Mahl
Restricted accessAbstractFirst published online September 22, 2023Topic: Education/Training Abstract ID: 18 The Efficacy and Yield of Routine Duodenal Biopsy Sampling and Histopathological Analysis Versus Endoscopic Gestalt for the Diagnostic Evaluation of Celiac Disease in Patients With Normal Endoscopic Findings: An Experience at a Tertiary Care CenterClive Miranda, Murad Ali, […], Muddasir Ayaz, Gregory Gudleski, and Thomas Mahl+2-2View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231189086
{"title":"Topic: Education/Training Abstract ID: 18 The Efficacy and Yield of Routine Duodenal Biopsy Sampling and Histopathological Analysis Versus Endoscopic Gestalt for the Diagnostic Evaluation of Celiac Disease in Patients With Normal Endoscopic Findings: An Experience at a Tertiary Care Center","authors":"Clive Miranda, Murad Ali, Muddasir Ayaz, Gregory Gudleski, Thomas Mahl","doi":"10.1177/26345161231189086","DOIUrl":"https://doi.org/10.1177/26345161231189086","url":null,"abstract":"Restricted accessAbstractFirst published online September 22, 2023Topic: Education/Training Abstract ID: 18 The Efficacy and Yield of Routine Duodenal Biopsy Sampling and Histopathological Analysis Versus Endoscopic Gestalt for the Diagnostic Evaluation of Celiac Disease in Patients With Normal Endoscopic Findings: An Experience at a Tertiary Care CenterClive Miranda, Murad Ali, […], Muddasir Ayaz, Gregory Gudleski, and Thomas Mahl+2-2View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231189086","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231195985
Brittany Harper, Gian Galura, Gilbert Aidinian, Richard McCallum, Brian Davis
Restricted accessAbstractFirst published online September 22, 2023Topic: Stomach Abstract ID: 73 Surgical Treatment of Median Arcuate Ligament Syndrome in a Series of Patients With GastroparesisBrittany Harper, Gian Galura, […], Gilbert Aidinian, Richard McCallum, and Brian Davis+2-2View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231195985
限制访问摘要首次在线发表于2023年9月22日主题:胃摘要ID: 73中位弓状韧带综合征在一系列胃异常患者中的手术治疗brittany Harper, Gian Galura，[…]，Gilbert Aidinian, Richard McCallum和Brian Davis+2-2查看所有作者和关系sonlinefirstttps://doi.org/10.1177/26345161231195985
{"title":"Topic: Stomach Abstract ID: 73 Surgical Treatment of Median Arcuate Ligament Syndrome in a Series of Patients With Gastroparesis","authors":"Brittany Harper, Gian Galura, Gilbert Aidinian, Richard McCallum, Brian Davis","doi":"10.1177/26345161231195985","DOIUrl":"https://doi.org/10.1177/26345161231195985","url":null,"abstract":"Restricted accessAbstractFirst published online September 22, 2023Topic: Stomach Abstract ID: 73 Surgical Treatment of Median Arcuate Ligament Syndrome in a Series of Patients With GastroparesisBrittany Harper, Gian Galura, […], Gilbert Aidinian, Richard McCallum, and Brian Davis+2-2View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231195985","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231195981
Alejandro Nieponice, Hugo Delle Donne, Mauricio Ramirez, David Solinas, Fabio Nachman, Adolfo Badaloni
longitudinal mucosotomy. Transverse mucosotomy significantly reduced time to enter the submucosal tunnel, time for tunnel closure
{"title":"Topic: InternationalAbstract ID: 70Transverse Mucosal Incision for POEM: Reducing Procedure Time and Clip Usage","authors":"Alejandro Nieponice, Hugo Delle Donne, Mauricio Ramirez, David Solinas, Fabio Nachman, Adolfo Badaloni","doi":"10.1177/26345161231195981","DOIUrl":"https://doi.org/10.1177/26345161231195981","url":null,"abstract":"longitudinal mucosotomy. Transverse mucosotomy significantly reduced time to enter the submucosal tunnel, time for tunnel closure","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"198 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134916327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231198887
Sanjay M. Salgado, D. Carr-Locke
Achalasia has become increasingly diagnosed in the last decade and has become an important therapeutic entity for advanced endoscopists since the advent of PerOral Endoscopic Myotomy (POEM). This treatment now provides a highly successful minimally-invasive approach which, for most patients, is an outpatient procedure. Consistent success depends on patient selection, sound technique and management of infrequent adverse events . This article focusses on these three areas and hopes to assist referring gastroenterologists in understanding the appropriateness of POEM for achalasia and to guide those endoscopists embarking on a POEM program in making decisons.
{"title":"Critical Decision-Making: Technical Aspects of Performing POEM","authors":"Sanjay M. Salgado, D. Carr-Locke","doi":"10.1177/26345161231198887","DOIUrl":"https://doi.org/10.1177/26345161231198887","url":null,"abstract":"Achalasia has become increasingly diagnosed in the last decade and has become an important therapeutic entity for advanced endoscopists since the advent of PerOral Endoscopic Myotomy (POEM). This treatment now provides a highly successful minimally-invasive approach which, for most patients, is an outpatient procedure. Consistent success depends on patient selection, sound technique and management of infrequent adverse events . This article focusses on these three areas and hopes to assist referring gastroenterologists in understanding the appropriateness of POEM for achalasia and to guide those endoscopists embarking on a POEM program in making decisons.","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"3 1","pages":"323 - 331"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66050700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231195983
Paul Wisniowski, Luke Putnam, Kamran Samakar, Vincent Cheng, James Nguyen, Adrian Dobrowolsky, Stuart Abel, Lauren Hawley, Caitlin Houghton, John Lipham
Restricted accessAbstractFirst published online September 22, 2023Topic: Bariatrics As It Relates to Foregut Disease Abstract ID: 72 Contemporary Analysis of Primary Gastric Bypass Compared to Revisional Gastric Bypass After Sleeve Gastrectomy in Obese Patients With Gastroesophageal RefluxPaul Wisniowski, Luke Putnam, […], Kamran Samakar, Vincent Cheng, James Nguyen, Adrian Dobrowolsky, Stuart Abel, Lauren Hawley, Caitlin Houghton, and John Lipham+7-7View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231195983
首次在线发表于2023年9月22日主题:肥胖与前肠疾病的关系[72]肥胖胃食管反流患者套管胃切除术后胃旁路与胃旁路的当代对比分析[j]， paul Wisniowski, Luke Putnam, Kamran Samakar, Vincent Cheng, James Nguyen, Adrian Dobrowolsky, Stuart Abel, Lauren Hawley, Caitlin Houghton, John Lipham+7-7查看所有作者和关系
{"title":"Topic: Bariatrics As It Relates to Foregut Disease Abstract ID: 72 Contemporary Analysis of Primary Gastric Bypass Compared to Revisional Gastric Bypass After Sleeve Gastrectomy in Obese Patients With Gastroesophageal Reflux","authors":"Paul Wisniowski, Luke Putnam, Kamran Samakar, Vincent Cheng, James Nguyen, Adrian Dobrowolsky, Stuart Abel, Lauren Hawley, Caitlin Houghton, John Lipham","doi":"10.1177/26345161231195983","DOIUrl":"https://doi.org/10.1177/26345161231195983","url":null,"abstract":"Restricted accessAbstractFirst published online September 22, 2023Topic: Bariatrics As It Relates to Foregut Disease Abstract ID: 72 Contemporary Analysis of Primary Gastric Bypass Compared to Revisional Gastric Bypass After Sleeve Gastrectomy in Obese Patients With Gastroesophageal RefluxPaul Wisniowski, Luke Putnam, […], Kamran Samakar, Vincent Cheng, James Nguyen, Adrian Dobrowolsky, Stuart Abel, Lauren Hawley, Caitlin Houghton, and John Lipham+7-7View all authors and affiliationsOnlineFirsthttps://doi.org/10.1177/26345161231195983","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135434118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26345161231196019
Federica Cucè
Laparoscopic Heller myotomy (LH) represents the gold standard treatment for symptomatic achalasia, robotic-assisted myotomy (RH) has shown promising improvement in safety and effectiveness. We aim to meta-analyse data comparing surgical outcomes and complications of LH and RH. A
{"title":"Topic: Esophagus Benign-GERD, Achalasia, Motility Abstract ID: 95 Heller Myotomy for Symptomatic Achalasia: Traditional or Robotic-Assisted Laparoscopy? A Systematic Review With Meta-Analysis","authors":"Federica Cucè","doi":"10.1177/26345161231196019","DOIUrl":"https://doi.org/10.1177/26345161231196019","url":null,"abstract":"Laparoscopic Heller myotomy (LH) represents the gold standard treatment for symptomatic achalasia, robotic-assisted myotomy (RH) has shown promising improvement in safety and effectiveness. We aim to meta-analyse data comparing surgical outcomes and complications of LH and RH. A","PeriodicalId":73049,"journal":{"name":"Foregut (Thousand Oaks, Calif.)","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134916326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：